SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Drossaers-Bakker KW, de Buck M, van Zeben D, Zwinderman AH, Breedveld FC, Hazes JM.Long-term course and outcome of functional capacity in rheumatoid arthritis: the effect of disease activity and radiologic damage over time.Arthritis Rheum1999;42:185460.
  • 2
    Welsing PM, van Gestel AM, Swinkels HL, Kiemeney LA, van Riel PL.The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis.Arthritis Rheum2001;44:200917.
  • 3
    Scott DL, Smith C, Kingsley G.Joint damage and disability in rheumatoid arthritis: an updated systematic review.Clin Exp Rheumatol2003;21 Suppl:S207.
  • 4
    Kingsley G, Scott IC, Scott DL.Quality of life and the outcome of established rheumatoid arthritis.Best Pract Res Clin Rheumatol2011;25:585606.
  • 5
    Smolen JS, Landewe R, Breedveld FC, Dougados M, Emery P, Gaujoux-Viala C, et al.EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs.Ann Rheum Dis2010;69:96475.
  • 6
    Van Tuyl LH, Felson DT, Wells G, Smolen J, Zhang B, Boers M, for the American College of Rheumatology and the European League Against Rheumatism Committee to Define Remission for Clinical Trials.Evidence for predictive validity of remission on long-term outcome in rheumatoid arthritis: a systematic review.Arthritis Care Res (Hoboken)2010;62:10817.
  • 7
    Scott DL.Biologics-based therapy for the treatment of rheumatoid arthritis.Clin Pharmacol Ther2012;91:3043.
  • 8
    Van der Kooij SM, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Guler-Yuksel M, Zwinderman AH, Kerstens PJ, et al.Drug-free remission, functioning and radiographic damage after 4 years of response-driven treatment in patients with recent-onset rheumatoid arthritis.Ann Rheum Dis2009;68:91421.
  • 9
    Verstappen SM, Jacobs JW, van der Veen MJ, Heurkens AH, Schenk Y, ter Borg EJ, et al.Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial).Ann Rheum Dis2007;66:14439.
  • 10
    Smolen JS, Aletaha D, Bijlsma JW, Breedveld FC, Boumpas D, Burmester G, et al.Treating rheumatoid arthritis to target: recommendations of an international task force.Ann Rheum Dis2010;69:6317.
  • 11
    Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL.Modified disease activity scores that include twenty-eight–joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.Arthritis Rheum1995;38:448.
  • 12
    Schipper LG, Vermeer M, Kuper HH, Hoekstra MO, Haagsma CJ, Broeder AA, et al.A tight control treatment strategy aiming for remission in early rheumatoid arthritis is more effective than usual care treatment in daily clinical practice: a study of two cohorts in the Dutch Rheumatoid Arthritis Monitoring registry.Ann Rheum Dis2012;71:84550.
  • 13
    Vermeer M, Kuper HH, Hoekstra M, Haagsma CJ, Posthumus MD, Brus HL, et al.Implementation of a treat-to-target strategy in very early rheumatoid arthritis: results of the Dutch Rheumatoid Arthritis Monitoring remission induction cohort study.Arthritis Rheum2011;63:286572.
  • 14
    Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al.The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.Arthritis Rheum1988;31:31524.
  • 15
    Fries JF, Spitz P, Kraines RG, Holman HR.Measurement of patient outcome in arthritis.Arthritis Rheum1980;23:13745.
  • 16
    Siegert CE, Vleming LJ, Vandenbroucke JP, Cats A.Measurement of disability in Dutch rheumatoid arthritis patients.Clin Rheumatol1984;3:3059.
  • 17
    Ware JE Jr, Sherbourne CD.The MOS 36-item Short-Form health survey (SF-36). I. Conceptual framework and item selection.Med Care1992;30:47383.
  • 18
    Van der Heijde DM.How to read radiographs according to the Sharp/van der Heijde method [corrected and republished in J Rheumatol 2000;27:261–3].J Rheumatol1999;26:7435.
  • 19
    Bruynesteyn K, van der Heijde D, Boers M, Saudan A, Peloso P, Paulus H, et al.Determination of the minimal clinically important difference in rheumatoid arthritis joint damage of the Sharp/van der Heijde and Larsen/Scott scoring methods by clinical experts and comparison with the smallest detectable difference.Arthritis Rheum2002;46:91320.
  • 20
    Felson DT, Smolen JS, Wells G, Zhang B, van Tuyl LH, Funovits J, et al.American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials.Arthritis Rheum2011;63:57386.
  • 21
    Vermeer M, Kuper HH, van der Bijl AE, Baan H, Posthumus MD, Brus HL, et al.The provisional ACR/EULAR definition of remission in RA: a comment on the patient global assessment criterion.Rheumatology (Oxford)2012;51:107680.
  • 22
    Mierau M, Schoels M, Gonda G, Fuchs J, Aletaha D, Smolen JS.Assessing remission in clinical practice.Rheumatology (Oxford)2007;46:9759.
  • 23
    Prince FH, Bykerk VP, Shadick NA, Lu B, Cui J, Frits M, et al.Sustained rheumatoid arthritis remission is uncommon in clinical practice.Arthritis Res Ther2012;14:R68.
  • 24
    Jayakumar K, Norton S, Dixey J, James D, Gough A, Williams P, et al.Sustained clinical remission in rheumatoid arthritis: prevalence and prognostic factors in an inception cohort of patients treated with conventional DMARDS.Rheumatology (Oxford)2012;51:16975.
  • 25
    Aletaha D.Nothing lasts forever: a critical look at sustained remission.Arthritis Res Ther2012;14:116.
  • 26
    Grigor C, Capell H, Stirling A, McMahon AD, Lock P, Vallance R, et al.Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial.Lancet2004;364:2639.
  • 27
    Schipper LG, Fransen J, den Broeder AA, van Riel PL.Time to achieve remission determines time to be in remission.Arthritis Res Ther2010;12:R97.
  • 28
    Menninger H, Meixner C, Sondgen W.Progression and repair in radiographs of hands and forefeet in early rheumatoid arthritis.J Rheumatol1995;22:104854.
  • 29
    Sharp JT, van der Heijde D, Boers M, Boonen A, Bruynesteyn K, Emery P, et al.Repair of erosions in rheumatoid arthritis does occur: results from 2 studies by the OMERACT Subcommittee on Healing of Erosions.J Rheumatol2003;30:11027.
  • 30
    Rau R.Is remission in rheumatoid arthritis associated with radiographic healing?Clin Exp Rheumatol2006;24 Suppl:S414.
  • 31
    Van der Heijde D, Landewe R, van Vollenhoven R, Fatenejad S, Klareskog L.Level of radiographic damage and radiographic progression are determinants of physical function: a longitudinal analysis of the TEMPO trial.Ann Rheum Dis2008;67:126770.
  • 32
    Bombardier C, Barbieri M, Parthan A, Zack DJ, Walker V, Macarios D, et al.The relationship between joint damage and functional disability in rheumatoid arthritis: a systematic review.Ann Rheum Dis2012;71:83644.
  • 33
    Landewe R, van der Heijde D, van der Linden S, Boers M.Twenty-eight-joint counts invalidate the DAS28 remission definition owing to the omission of the lower extremity joints: a comparison with the original DAS remission.Ann Rheum Dis2006;65:63741.
  • 34
    Gaujoux-Viala C, Mouterde G, Baillet A, Claudepierre P, Fautrel B, Le Loet X, et al.Evaluating disease activity in rheumatoid arthritis: which composite index is best? A systematic literature analysis of studies comparing the psychometric properties of the DAS, DAS28, SDAI and CDAI.Joint Bone Spine2012;79:14955.
  • 35
    Bakker MF, Jacobs JW, Kruize AA, van der Veen MJ, van Booma-Frankfort C, Vreugdenhil SA, et al.Misclassification of disease activity when assessing individual patients with early rheumatoid arthritis using disease activity indices that do not include joints of feet.Ann Rheum Dis2012;71:8305.